Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. financial statements

Aspire Biopharma Holdings, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 6.2K10-K/A
Net income−USD 24.48M10-K/A
Cash and equivalentsUSD 1M10-Q
Total debtUSD 1.38MEODHD

Aspire Biopharma Holdings, Inc. financials on 6ix · Aspire Biopharma Holdings, Inc. on 6ix